[Administration of essential phospholipids in persons exposed to chemical industrial pollutants].
OBJECTIVE
To examine efficacy of the drug essliver-forte in patients with chronic intoxication by a complex of such toxicants as soluble and unsoluble compounds of uranium, lead and mercury.


METHODS
The examination of bilirubin, synthesis of proteins and enzyme production by the liver, activity of free radical lipid oxidation and antioxidant defence was conducted in 42 persons (mean age 66.4 +/- 4.2 years) occupationally exposed to chemicals (compounds of uranium, lead and mercury) for 12.6 +/- 1.8 years. The patients were divided into two equal groups: patients of group 1 received standard therapy with enterosorbents, cerebral angioprotectors and alpha-tocopherol; patients of group 2 instead of alpha-tocopherol were given essliver-forte (2 capsules twice a day).


RESULTS
Patients of group 2 had significantly less frequent complaints for fatigue, anxiety, dyspnea, sleep disorders; improvement was observed in peripheral blood counts, in concentrations of alpha 2- and gamma-globulins, sulfhydril and catalase activity of erythrocytes; transaminase activity and intensity of saponin hemolysis went down.


CONCLUSIONS
Essliver-forte is effective in persons occupationally exposed to chemicals.
Shpagina
L A
LA
Bobrov
S V
SV
D000975:Antioxidants / Q000008:administration & dosage / Q000627:therapeutic use*; D015386:Hazardous Substances / Q000506:poisoning*; D006801:Humans; D008111:Liver Function Tests; D009784:Occupational Diseases / Q000188:drug therapy* / Q000209:etiology; D016273:Occupational Exposure / Q000009:adverse effects*; D010713:Phosphatidylcholines / Q000008:administration & dosage / Q000627:therapeutic use*; D011041:Poisoning / Q000188:drug therapy / Q000209:etiology; D012426:Russia; D016896:Treatment Outcome
D000975:Antioxidants; D015386:Hazardous Substances; D010713:Phosphatidylcholines; C011246:essential 303 forte